Premium
Two different initial treatment regimens of ranibizumab in myopic choroidal neovascularization: 12‐Month results from a randomized controlled study—Response
Author(s) -
Li Songshan,
Ding Xiaoyan,
Zhang Junyan,
Lu Lin
Publication year - 2019
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1111/ceo.13507
Subject(s) - medicine , ranibizumab , choroidal neovascularization , ophthalmology , randomized controlled trial , bevacizumab , visual acuity , surgery , chemotherapy